Aclarion, Inc. , a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States.
Aclarion stock last closed at $8.98, down 1.32% from the previous day, and has decreased 99.67% in one year. It has underperformed other stocks in the Health Information Services industry by 0.29 percentage points. Aclarion stock is currently +23.69% from its 52-week low of $7.26, and -99.86% from its 52-week high of $6,241.05.
As of Apr 17, 2025, there are 582,371 ACON shares outstanding. The market capitalization of ACON is $5.23M. In the past 24 hours, 18,007 ACON shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy ACON shares.
Based on our experience, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, it's time to fill out some personal information so you are able to buy ACON stock today.
Now that you've finished signing up on stock apps to use, you can securely and quickly fund your account:
Watch the walkthrough below if you need help transferring money into your new investment account.
After you have chosen the best place to buy Aclarion stock, it's very important to evaluate their stock before you buy, so you truly comprehend the risk and upside.
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on ACON's stock page.
You can use many financial metrics, analyses, models, and charts to gauge ACON's fair value.
Using relative valuations measures:
You can do additional valuation research on ACON's stock here.
Out of 1 Wall Street analysts who give forecasts on ACON, the consensus analyst rating on Aclarion is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Aclarion stock forecast page.
Last year, ACON revenue was $45.72k. During the past 4 year, ACON's revenue has increased by -1.54% per year. This was slower than the Health Information Services industry average of 22.45%.
Dive into ACON's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at ACON have not bought or sold any shares.
Dig into more about who owns ACON shares here.
No, Aclarion doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary options:
Hit the Open Trade button and eToro will execute the order.
If you want additional help investing in stocks on eToro, click the helpful video below:
Now that you own some ACON shares, you'll want to keep up with your company.
Make a watchlist to get notified of important updates regarding your ACON stock.
To reiterate, here are the 6 steps to buy stock in Aclarion:
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Aclarion, create a watchlist on WallStreetZen today.